imatinib mesylate has been researched along with Neurofibroma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chhabra, G; Verma, P | 1 |
Burns, D; Chen, S; Clapp, DW; Horn, W; Hutchins, G; Ingram, DA; Knowles, S; Li, X; Li, Y; Parada, LF; Robertson, K; Vakili, ST; Yang, FC; Yang, X; Yang, Y; Yu, M; Yuan, J; Zhang, S; Zhu, Y | 1 |
Clapp, DW; Staser, K; Yang, FC | 1 |
Burgin, S; Chen, S; Clapp, DW; Clegg, T; Estwick, SA; Ingram, DA; Khalaf, W; Li, X; Morgan, T; Parada, LF; Travers, J; Yang, FC; Yuan, J | 1 |
1 review(s) available for imatinib mesylate and Neurofibroma
Article | Year |
---|---|
Mast cells and the neurofibroma microenvironment.
Topics: Animals; Antineoplastic Agents; Benzamides; Child, Preschool; Female; Humans; Imatinib Mesylate; Mast Cells; Neurofibroma; Neurofibromatosis 1; Piperazines; Pyrimidines | 2010 |
3 other study(ies) available for imatinib mesylate and Neurofibroma
Article | Year |
---|---|
Successful treatment of cutaneous (dermal) neurofibromas with imatinib mesylate.
Topics: Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Neurofibroma; Piperazines | 2020 |
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
Topics: Animals; Benzamides; Bone Marrow; Bone Marrow Transplantation; Child, Preschool; Genes, Neurofibromatosis 1; Humans; Imatinib Mesylate; Mast Cells; Mice; Mice, Inbred C57BL; Neurofibroma; Neurofibroma, Plexiform; Neurofibromin 1; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Schwann Cells | 2008 |
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.
Topics: Animals; Benzamides; Bone Marrow Cells; Cell Movement; Cell Proliferation; Collagen; Culture Media, Conditioned; Embryo, Mammalian; Fibroblasts; Fibrosis; Haplotypes; Heterozygote; Humans; Imatinib Mesylate; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurofibroma; Neurofibromatosis 1; Phenotype; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins p21(ras); Pyrimidines; Signal Transduction; Transforming Growth Factor beta | 2006 |